Understanding Poverty-Related Diseases in Cameroon from a Salutogenic Perspective
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Discussion Piece Reflecting on the Recent Implementation of Programmes and Policies Supported by the World Bank in Benin, Camero
COMMUNITY-BASED RESULTS-BASED FINANCING IN HEALTH IN PRACTICE. A discussion piece reflecting on the recent implementation of programmes and policies supported by the World Bank in Benin, Cameroon, the Republic of Congo, the Democratic Republic of the Congo, The Gambia, and Rwanda Jean-Benoît Falisse, Petra Vergeer, Maud Juquois, Alphonse Akpamoli, Jacob Paul Robyn, Walters Shu, Michel Zabiti, Rifat Hasan, Bakary Jallow, Musa Loum, Cédric Ndizeye, Michel Muvudi, Baudouin Makuma Booto Joy Gebre Medhin Executive summary This report discusses Community Results-Based Financing (cRBF), a 'close to client' approach whereby community actors are paid based on the activities they undertake. The focus is on six developing cRBF experiences that have started in Cameroon, The Gambia, Benin, the Democratic Republic of the Congo (DR Congo), Rwanda, and the Republic of Congo. The report's main aim is to cast light on the success and difficulties encountered in the implementation of such a programme. The report is based on a participative process that included a short review of the existing literature on cRBF, a review of the manuals of procedures and reports produced in each country case, in-depth interviews with a focal point in five countries, and two workshops with practitioners. Do cRBF schemes work? It is too early to say: most schemes are still in their infancy. An impact evaluation of the Rwandan scheme found mixed effects. The Cameroon, Congo, and the Gambia schemes integrate rigorous impact evaluation mechanisms and the first results should be available in two to five years. At this stage, the main discussion is on the implementation of cRBF. -
Infectious Diseases of Poverty, the First Five Years
Wang et al. Infectious Diseases of Poverty (2017) 6:96 DOI 10.1186/s40249-017-0310-6 EDITORIAL Open Access Infectious Diseases of Poverty, the first five years Wei Wang1,2,3,4, Jin Chen5,6,7, Hui-Feng Sheng5,6,7, Na-Na Wang8, Pin Yang5,6,7*, Xiao-Nong Zhou5,6,7 and Robert Bergquist9 Abstract Although the focus in the area of health research may be shifting from infectious to non-communicable diseases, the infectious diseases of poverty remain a major burden of disease of global health concern. A global platform to communicate and share the research on these diseases is needed to facilitate the translation of knowledge into effective approaches and tools for their elimination. Based on the “One health, One world” mission, a new, open- access journal, Infectious Diseases of Poverty (IDP), was launched by BioMed Central in partnership with the National Institute of Parasitic Diseases (NIPD), Chinese Center for Disease Control and Prevention (China CDC) on October 25, 2012. Its aim is to identify and assess research and information gaps that hinder progress towards new interventions for a particular public health problem in the developing world. From the inaugural IDP issue of October 25, 2012, a total of 256 manuscripts have been published over the following five years. Apart from a small number of editorials, opinions, commentaries and letters to the editor, the predominant types of publications are research articles (69.5%) and scoping reviews (21.5%). A total of 1 081 contributing authors divided between 323 affiliations across 68 countries, territories and regions produced these 256 publications. -
WHO in Cameroon
Summary : Pages List of abbreviations 3 Editorial 5 7 Highlights of 2016 6 Significant quotes in 2016 8 Figures , charts and tables 9 Introduction 10 1. Communicable Diseases 12 1.1. HIV / AIDS 1.2. TUBERCULOSIS 14 1.3. MALARIA 1.4. NEGLECTED TROPICAL DISEASES 15 1.5. VACCINE PREVENTABLE DISEASES 19 6 2. Noncommunicable Diseases 24 2.1. NONCOMMUNICABLE DISEASES 2.2. NUTRITION 25 3. Promoting health at all stages of life 25 3.1. REPRODUCTIVE, MATERNAL, NEWBORN, CHILD AND ADOLESCENT HEALTH. 4. Health Systems 31 4.1. NATIONAL HEALTH POLICIES, STRATEGIES AND PLANS 4.2. ACCESS TO DRUGS AND HEALTH TECHNOLOGIES, AND STRENGTHENING REGULATORY MEASURES 4.3. INFORMATION AND DATA ON HEALTH SYSTEMS 32 5. Preparedness, monitoring and response 33 5.1. ALERT AND INTERVENTION CAPACITIES 5.2. MANAGEMENT OF CRISES AND RISKS ASSOCIATED WITH EMERGENCIES 35 5.3. POLIOMYELITIS ERADICATION 36 6. Institutional and Support Services 42 6.1. PROGRAMME SUPPORT (COUNTRY SUPPORT UNIT) 6.2. HUMAN RESOURCES 43 6.3. FINANCIAL MANAGEMENT AND INTERNAL CONTROL 6.4. IMPROVEMENT OF THE WORKING ENVIRONMENT 45 6.5. INFORMATION AND COMMUNICATION TECHNOLOGIES 14 6.6. COMMUNICATION SUPPORT PROGRAMMES 46 >> The faces of the office 47 - 50 ANNEX 51 Acknowledgements Annex 1 : Obstacles and constraints 52 Throughout the year, we worked with the Lessons learned Ministry of Public Health, the Government Prospects for the year 2017 53 of Cameroon, numerous bilateral and Annex 2 : Support received from IST – AFRO - HQ 54 multilateral partners, governmental orga - nizations and the civil society. Annex 3 : Assistance Missions to the Country We therefore express to them our deepest Annex 4 : List of documents produced 55 appreciation. -
Diseases of Poverty and the 10/90 Gap
4 Diseases of poverty and the 10/90 Gap Philip Stevens Introduction: What is the 10/90 Gap? Activists claim that only 10 per cent of global health research is devoted to conditions that account for 90 per cent of the global disease burden – the so-called ‘10/90 Gap’ (Medecins Sans Frontiers, 2001). They argue that virtually all diseases prevalent in low income countries are ‘neglected’ and that the pharmaceutical industry has invested almost nothing in research and development (R&D) for these diseases. Citing this alleged imbalance as justification, activists have for some years been calling for a complete redesign of the current R&D paradigm in order to ensure that more attention is paid to these ‘neglected diseases’ (Love & Hubbard, 2003). This could include measures such as an ‘essential research obligation’ that would require companies to reinvest a percentage of pharmaceutical sales into R&D for neglected diseases, either directly or through public R&D programs (Medecins Sans Frontiers, 2001), or the creation of a new public entity to direct R&D. This topic is now under discussion by a World Health Organisation working group following the report of its Commission on Intellectual Property, Innovation and Public Health.1 But does such an imbalance really exist and what would be the effect of redesigning the R&D system? This chapter investigates the realities of the 10/90 gap and its relation to the diseases of poverty. Diseases of poverty and the 10/90 gap 127 Neglected diseases Many scholars and activists have suggested that because there is little market for treatments for tropical infectious diseases such as leishmaniasis, lymphatic filariasis, Chagas’ disease, leprosy, Guinea worm, onchocerciasis and schistosomiasis, there is a consequent lack of suitable drugs. -
1 Why Research Infectious Diseases of Poverty?
1 Why research infectious diseases of poverty? 11 in chapteR 1: • Poverty and infectious disease – a problematic relationship • infectious disease – the true burden on communities • the value of research: new ways to end old diseases • moving beyond the Millennium Development Goals • the cost of inaction – social and economic consequences • tackling disease – a need for investment • ten reasons to research infectious diseases of poverty AUTHORS Research is the key to making things Professor SiAn GRiffiths happen for poor populations. This Director, School of Public Health introductory chapter of the Global and Primary Care, The ChineSe Report examines the need for research univerSity of Hong Kong, Hong into the infectious diseases that Kong SPecial AdminiStrative region, China disproportionately affect poor and marginalized communities – the so- Professor Xiao-NonG Zhou Director, National InStitute called “infectious diseases of poverty”. of ParaSitic DiSeaSeS, ChineSe It examines the link between poverty center for DiSeaSe Control anD and disease and outlines ten reasons Prevention, Shanghai, China to support research for such diseases. Such research represents unfinished Report fellOw Allison Thorpe business of global relevance, work that the world can no longer afford to neglect. 11 According to the latest published data in 2012, infectious (including parasitic) diseases were together responsible for the death of more than 8.7 million people worldwide in 2008 (1). The majority of these deaths were of poor people living in low and middle- income countries, with many of the deaths Infectious diseases have occurring in children under five years of age. shaped societies, driven Given the sketchy data, misdiagnosis and conflict and spawned the under-detection that are typical of health marginalization of infected systems in impoverished areas, these num- individuals and communities bers are almost certainly underestimated. -
Banking on Health: World Bank and African Development Bank Spending on Reproductive Health And
Banking on Health: World Bank and African Development Bank Spending on Reproductive Health and HIV/AIDS in Sub-Saharan Africa i Publication prepared by: Claire Lauterbach, Programs Associate, Gender Action With contributions from: Elaine Zuckerman, President, Gender Action Elizabeth Arend, former Programs Coordinator, Gender Action Patience Nyangoma, Executive Director, NAWAD Christian Tanyi, Chief Executive Officer, LUKMEF With support from: The William and Flora Hewlett Foundation The Tides Foundation Copyright © Gender Action 2012 About Gender Action Gender Action was established in 2002. It is the only organization dedicated to promoting gender justice and women’s rights in all International Financial Institution (IFI) investments such as those of the World Bank. Gender Action’s goal is to ensure that women and men equally participate in and benefit from all IFI investments. Gender Action 1875 Connecticut Avenue NW Suite 500 Washington DC 20009, USA Tel: 202 939 5463 Email: [email protected] http://www.genderaction.org ii Table of Contents List of Abbreviations .................................................................................................................................... iv Executive Summary....................................................................................................................................... v Introduction ..................................................................................................................................................1 Population and reproductive -
Diseases of Poverty and the 10/90 Gap Diseases of Poverty and the 10/90 Gap Diseases of Poverty and the 10/90 Gap
Diseases of poverty and the 10/90 gap Diseases of poverty and the 10/90 Gap Diseases of poverty and the 10/90 Gap Written by Philip Stevens, Director of Health Projects, International Policy Network November 2004 International Policy Network Third Floor, Bedford Chambers The Piazza London WC2E 8HA UK t : +4420 7836 0750 f: +4420 7836 0756 e: [email protected] w : www.policynetwork.net © International Policy Network 2004 Designed and typeset in Latin 725 by MacGuru Ltd [email protected] Cover design by Sarah Hyndman Printed in Great Britain by Hanway Print Centre 102–106 Essex Road Islington N1 8LU All rights reserved. Without limiting the rights under copyright reserved above, no part of this publication may be reproduced, stored or introduced into a retrieval system, or transmitted, in any form or by any means (electronic, mechanical, photocopying, recording or otherwise) without the prior written permission of both the copyright owner and the publisher of this book. Diseases of poverty and the 10/90 Gap Introduction: What is the 10/90 Gap? Figure 1 Number of daily deaths from diseases7 Activists claim that only 10 per cent of global health research is devoted to conditions that account for 90 Respiratory 10,814 per cent of the global disease burden – the so-called infections 1 ‘10/90 Gap’. They argue that virtually all diseases HIV/ 7,852 AIDS prevalent in low income countries are ‘neglected’ Diarrhoeal 5,482 and that the pharmaceutical industry has invested diseases almost nothing in research and development (R&D) Tuberculosis 4,504 for these diseases. -
Global Report for Research on Infectious Diseases of Poverty 2012
global reporT for research on infectious diseases of poverty 2012 wiTh financial supporT of European Union global report for research on infectious diseases of poverty with financial support of European Union WHo library Cataloguing-in-publication Data: Global report for research on infectious diseases of poverty. 1.communicable disease control. 2.research 3.poverty. 4.health behavior. 5.developing countries. i.World health organiza- tion. ii.unicef/undp/World Bank/Who special programme for research and training in tropical diseases. isBn 978 92 4 156 448 9 (nLM classification: aW 110) Copyright © World Health organization on behalf of the Special programme for research and training in tropical Diseases 2012 all rights reserved. the use of content from this health information product for all non-commercial education, training and information purposes is encouraged, including translation, quotation and reproduction, in any medium, but the content must not be changed and full acknowledgement of the source must be clearly stated. a copy of any resulting product with such content should be sent to tdr, World health organization, avenue appia, 1211 Geneva 27, switzerland. tdr is a World health organi- zation (Who) executed unicef/undp/World Bank/World health organization special programme for research and training in tropical diseases. this information product is not for sale. the use of any information or content whatsoever from it for publicity or advertising, or for any commercial or income-generating purpose, is strictly prohibited. no elements of this information product, in part or in whole, may be used to promote any specific individual, entity or product, in any manner whatsoever. -
Factors Associated with Cholera Outbreaks, Nairobi County, July 2017: a Case Control Study
bioRxiv preprint doi: https://doi.org/10.1101/719641; this version posted July 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Factors associated with cholera outbreaks, Nairobi County, July 2017: a case control study Valerian Mwenda1* [email protected] Alexis Niyomwungere1, 2 [email protected] Elvis Oyugi 1 [email protected] Jane Githuku1 [email protected] Mark Obonyo3 [email protected] Zeinab Gura1 [email protected] 1Field Epidemiology and Laboratory Training Programme, Ministry of Health, Nairobi, Kenya 2Disease Surveillance and Response Unit, Ministry of Health, Nairobi, Kenya *Corresponding author. Abstract word count: 295 (with subheadings) Manuscript body ward count: 2586 Key words: Risk factors, cholera, Nairobi 1 bioRxiv preprint doi: https://doi.org/10.1101/719641; this version posted July 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Abstract 2 Background 3 Cholera affects 1.3-4 million people globally and causes 21000-143,000 deaths 4 annually. Nairobi County in Kenya reported cholera cases since April 2017. We investigated to 5 identify associated factors and institute control measures. 6 Methods 7 We reviewed the line-list of patients admitted at the Kenyatta National referral Hospital, 8 Nairobi and performed descriptive epidemiology. -
Health Care System and Health Financing Structure, the Case of Cameroon
IAAOJ, Health Science, 2013,1(2), 24-44 HEALTH CARE SYSTEM AND HEALTH FINANCING STRUCTURE, THE CASE OF CAMEROON Hayriye IŞIK1, Hubert NDIFUSAH2 1 NKU FEAS Department of Public Finance 2 NKU Institute of Social Science Department of Health Care Management ABSTRACT The purpose of this study is to identify healthcare systems and its financial components of Cameroon. As we know, Health care financing studies in Africa and cross-national levels have tended to focus on many modes of financing at a time, such as user fees, insurance,government budget, external aid, also on financing-related issues such as equity and quality of care. Relatively few attempts have been made in the literature to analyze total national health financing from all sources and to relate them to their various uses. This study also uses the broader framework of National Health Accounts (NHA) to analyze national health system and financing in Cameroon. Health care financing is one of the fastest growing areas in the field of public health economics. Health systems are defined as comprising all the organizations, institutions and resources that are devoted to producing health activities. Due to that reasons this study examined the challenges of health system and financing health care in Cameroon. It also identified various funding mechanisms available to finance health care in Cameroon. Key Words: Healthcare System, financing, funding mechanisms and Cameroon Isık and et al. ÖZET Bu çalışmanın amacı Kamerun sağlık sisteminin ve sistemin finansal bileşenlerini tanımlamaktır. Bildiğimiz gibi, Afrika ve uluslar arası düzeyde sağlık hizmet finansmanı çalışmalarında tüketici ödemeleri, sigorta, kamu bütçe kaynakları, dış yardımlar gibi çeşitli yöntem eğilimlerinin yanı sıra hizmet etkinliği ve kalitesi gibi finansmanla alakalı konular vardır. -
WEEKLY BULLETIN on OUTBREAKS and OTHER EMERGENCIES Week 12: 16 - 22 March 2020 Data As Reported By: 17:00; 22 March 2020
WEEKLY BULLETIN ON OUTBREAKS AND OTHER EMERGENCIES Week 12: 16 - 22 March 2020 Data as reported by: 17:00; 22 March 2020 REGIONAL OFFICE FOR Africa WHO Health Emergencies Programme 7 95 91 11 New events Ongoing events Outbreaks Humanitarian crises 201 17 Algeria 1 0 91 0 2 0 Gambia 1 0 1 0 Mauritania 14 7 20 0 9 0 Senegal 304 1 1 0Eritrea Niger 2 410 23 Mali 67 0 1 0 3 0 Burkina Faso 41 7 1 0 Cabo Verdé Guinea Chad 1 251 0 75 3 53 0 4 0 4 690 18 4 1 22 0 21 0 Nigeria 2 0 Côte d’Ivoire 1 873 895 15 4 0 South Sudan 917 172 40 0 3 970 64 Ghana16 0 139 0 186 3 1 0 14 0 Liberia 25 0 Central African Benin Cameroon 19 0 4 732 26 Ethiopia 24 0 Republic Togo 1 618 5 7 626 83 352 14 1 449 71 2 1 Uganda 36 16 Democratic Republic 637 1 169 0 9 0 15 0 Equatorial of Congo 15 5 202 0 Congo 1 0 Guinea 6 0 3 453 2 273 Kenya 1 0 253 1 Legend 3 0 6 0 38 0 37 0 Gabon 29 981 384 Rwanda 21 0 Measles Humanitarian crisis 2 0 4 0 4 998 63 Burundi 7 0 Hepatitis E 8 0 Monkeypox 8 892 300 3 294 Seychelles 30 2 108 0 Tanzania Yellow fever 12 0 Lassa fever 79 0 Dengue fever Cholera Angola 547 14 Ebola virus disease Rift Valley Fever Comoros 129 0 2 0 Chikungunya Malawi 218 0 cVDPV2 2 0 Zambia Leishmaniasis Mozambique 3 0 3 0 COVID-19 Plague Zimbabwe 313 13 Madagascar Anthrax Crimean-Congo haemorrhagic fever Namibia 286 1 Malaria 2 0 24 2 12 0 Floods Meningitis 3 0 Mauritius Cases 7 063 59 1 0 Deaths Countries reported in the document Non WHO African Region Eswatini N WHO Member States with no reported events W E 3 0 Lesotho4 0 402 0 South Africa 20 0 S South Africa Graded events † 40 15 1 Grade 3 events Grade 2 events Grade 1 events 39 22 20 31 Ungraded events ProtractedProtracted 3 3 events events Protracted 2 events ProtractedProtracted 1 1 events event Health Emergency Information and Risk Assessment Overview This Weekly Bulletin focuses on public health emergencies occurring in the WHO Contents African Region. -
Assessment of the Response to Cholera Outbreaks in Two Districts in Ghana Sally-Ann Ohene1*, Wisdom Klenyuie2 and Mark Sarpeh3
Ohene et al. Infectious Diseases of Poverty (2016) 5:99 DOI 10.1186/s40249-016-0192-z RESEARCH ARTICLE Open Access Assessment of the response to cholera outbreaks in two districts in Ghana Sally-Ann Ohene1*, Wisdom Klenyuie2 and Mark Sarpeh3 Abstract Background: Despite recurring outbreaks of cholera in Ghana, very little has been reported on assessments of outbreak response activities undertaken in affected areas. This study assessed the response activities undertaken in two districts, Akatsi District in Volta Region and Komenda-Edina-Eguafo-Abirem (KEEA) Municipal in Central Region during the 2012 cholera epidemic in Ghana. Methods: We conducted a retrospective assessment of the events, strengths and weaknesses of the cholera outbreak response activities in the two districts making use of the WHO cholera evaluation tool. Information sources included surveillance and facility records, reports and interviews with relevant health personnel involved in the outbreak response from both district health directorates and health facilities. We collected data on age, sex, area of residence, date of reporting to health facility of cholera cases, district population data and information on the outbreak response activities and performed descriptive analyses of the outbreak data by person, time and place. Results: The cholera outbreak in Akatsi was explosive with a high attack rate (AR) of 374/100,000 and case fatality rate (CFR) of 1.2 % while that in KEEA was on a relatively smaller scale AR of 23/100,000 but with a high case fatality rate of 18.8 %. For both districts, we identified multiple strengths in the response to the outbreak including timely notification of the district health officials which triggered prompt investigation of the suspected outbreak facilitating confirmation of cholera and initiation of public health response activities.